Erbe wins Microsoft Intelligent Manufacturing Award for EvidenceStream
Erbe Elektromedizin GmbH has been awarded the Microsoft Intelligent Manufacturing Award (MIMA) 2026 in the “Small and Medium Enterprises (SME)” category. The award recognizes the AI-based platform EvidenceStream, developed in collaboration with Flinn.ai, which enables Erbe to systematically unlock clinical evidence and make it usable for key business processes.
Focus on evidence-based decision-making
With EvidenceStream, Erbe strengthens its consistent focus on scientifically sound decision-making. The platform automatically analyzes and structures medical literature, making it available for regulatory, strategic, and product-related use.
The solution meets the requirements of the EU Medical Device Regulation (MDR) and is already used across more than 60 product groups.
For Erbe, this means:
- evidence-based product development
- well-founded performance evaluations and regulatory documentation
- continuous access to up-to-date clinical insights
Greater efficiency through AI support
By using EvidenceStream, Erbe significantly optimizes internal processes. Analysis and evaluation tasks can now be completed in roughly half the time compared to before. In addition, redundant workflows across departments are reduced.
Within the first year:
- more than 5,000 abstract screenings
- 97 literature analyses
were conducted.
The time gained is deliberately used for scientific evaluation and strategic decision-making.
Focus on expertise rather than administration
“As a medium-sized company operating in a highly regulated environment, we cannot afford inefficiencies or the loss of highly qualified professionals due to administrative burdens. EvidenceStream addresses both challenges. It demonstrates that the use of AI in medical technology is not about reducing staff, but about building organizational intelligence and ensuring competitiveness,” says Prof. Dr. med. Markus Enderle, Chief Scientific and Medical Officer and Member of the Executive Board of the Erbe Group.
Prof. Dr. Nermin Salkic, Global Medical Director of the Erbe Group, adds: “Our approach was clear: AI takes over repetitive tasks so that our experts can focus on evaluation and interpretation. EvidenceStream transforms fragmented clinical data into well-founded decisions that directly benefit patients.”
Award in the anniversary year
The MIMA award highlights Erbe’s commitment to combining medical innovation with technological excellence and actively shaping the digital transformation of medical technology. In 2026, the company also celebrates its 175th anniversary—an opportunity to further unite innovation and experience.